Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q6)Dec 31, 2025 | (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 121.51%54.48M | ---- | 70.45%-253.32M | ---- | -641.95%-857.4M | ---- | 59.32%-115.56M | ---- | -695.43%-284.07M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -40.76%-3.69M | ---- | 86.64%-2.62M | ---- | 27.64%-19.59M | ---- | -255.04%-27.08M | ---- | -5,952.38%-7.63M |
| Impairment and provisions: | ---- | -111.12%-6.1M | ---- | -73.36%54.83M | ---- | 299.28%205.83M | ---- | 127.90%51.55M | ---- | --22.62M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --16.93M |
| -Impairment of trade receivables (reversal) | ---- | -72.02%680K | ---- | 9.21%2.43M | ---- | --2.23M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -112.93%-6.78M | ---- | -74.26%52.4M | ---- | 294.96%203.61M | ---- | 805.36%51.55M | ---- | --5.69M |
| Revaluation surplus: | ---- | -78.35%56.48M | ---- | -63.78%260.87M | ---- | 342.80%720.23M | ---- | -38.28%162.65M | ---- | 242.11%263.54M |
| -Fair value of investment properties (increase) | ---- | -78.35%56.48M | ---- | -63.78%260.87M | ---- | 342.80%720.23M | ---- | -37.57%162.65M | ---- | 234.99%260.55M |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 501.75%2.99M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.09%9.17M | ---- | --30.67M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -70.03%9.17M | ---- | --30.6M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --65K |
| Depreciation and amortization: | ---- | 162.42%2.19M | ---- | -39.59%833K | ---- | 9.88%1.38M | ---- | -76.59%1.26M | ---- | 63.18%5.36M |
| Financial expense | ---- | -36.31%25.15M | ---- | -9.77%39.49M | ---- | -8.57%43.76M | ---- | -27.74%47.87M | ---- | 6.94%66.24M |
| Special items | ---- | -139.21%-99.74M | ---- | ---41.7M | ---- | ---- | ---- | --6.81M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -50.73%28.77M | ---- | -38.03%58.38M | ---- | -31.07%94.21M | ---- | 41.29%136.67M | ---- | 15.26%96.73M |
| Change of operating capital | ||||||||||
| Accounts receivable (increase)decrease | ---- | -370.91%-7.84M | ---- | 96.10%-1.66M | ---- | -1,287.38%-42.65M | ---- | 82.63%-3.07M | ---- | -244.07%-17.7M |
| Accounts payable increase (decrease) | ---- | 11,425.93%6.12M | ---- | -100.37%-54K | ---- | 19.48%14.46M | ---- | -75.29%12.11M | ---- | 884.75%48.99M |
| Advance payment increase (decrease) | ---- | ---858K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---287.13M |
| prepayments (increase)decrease | ---- | ---4.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | 110.95%597K | ---- | -86.36%283K | ---- | 119.70%2.08M | ---- | -108.45%-10.53M | ---- | 34.01%-5.05M |
| Cash from business operations | ---- | -61.13%22.13M | ---- | -16.38%56.95M | ---- | -49.62%68.1M | ---- | 182.34%135.17M | ---- | -299.43%-164.15M |
| Other taxs | ---- | 73.39%-1.65M | ---- | 15.07%-6.19M | ---- | 54.92%-7.29M | ---- | -363.66%-16.18M | ---- | 39.76%-3.49M |
| Special items of business | 1,165.33%33.51M | ---- | -88.52%2.65M | ---- | 8.37%23.08M | ---- | -93.67%21.29M | ---- | 894.81%336.22M | ---- |
| Net cash from operations | 1,165.33%33.51M | -59.64%20.49M | -88.52%2.65M | -16.53%50.75M | 8.37%23.08M | -48.90%60.81M | -93.67%21.29M | 170.98%118.99M | 894.81%336.22M | -319.08%-167.64M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -66.67%12K | -56.69%55K | 0.00%36K | 122.81%127K | 111.76%36K | -92.65%57K | -99.50%17K | -78.15%776K | -1.60%3.37M | 2,719.05%3.55M |
| Loan receivable (increase) decrease | -63.64%800K | -39.41%11.7M | -94.10%2.2M | -42.71%19.31M | 66.03%37.31M | -30.06%33.71M | -53.37%22.47M | 116.39%48.19M | --48.19M | ---294.12M |
| Purchase of fixed assets | ---- | -3,688.57%-2.65M | -4,031.75%-2.6M | 65.52%-70K | ---63K | 94.90%-203K | ---- | 62.88%-3.98M | 53.02%-4.63M | -65.94%-10.73M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.31M | ---4.31M | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 481.26%258.71M | ---46K | -130.20%-67.86M |
| Acquisition of subsidiaries | ---- | --3.39M | --3.39M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---901K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | -102.94%-89K | -35.47%12.5M | -91.88%3.03M | -42.29%19.37M | 65.78%37.28M | -88.79%33.56M | -47.18%22.49M | 181.10%299.39M | 761.99%42.58M | -269.04%-369.15M |
| Net cash before financing | 488.85%33.42M | -52.96%32.98M | -90.60%5.68M | -25.70%70.12M | 37.86%60.36M | -77.44%94.37M | -88.44%43.78M | 177.94%418.39M | 1,284.23%378.8M | -282.03%-536.79M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -83.08%2.44M | 376.59%19.85M | 15.63%14.42M | -73.07%4.16M | 258.24%12.47M | -94.79%15.46M | --3.48M | -35.68%296.75M | ---- | -48.10%461.34M |
| Refund | 84.56%-800K | -7,224.74%-14.21M | -2,556.41%-5.18M | 99.69%-194K | 99.60%-195K | 79.11%-61.97M | -126.32%-48.57M | -57.34%-296.71M | 73.03%-21.46M | 74.02%-188.58M |
| Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.70%-88K | -7.15%-62.36M |
| Dividends paid - financing | ---- | ---- | ---- | ---2.69M | ---- | ---- | ---- | -2,552.15%-215.09M | ---- | 27.91%-8.11M |
| Absorb investment income | 6,560.00%333K | --113K | --5K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 0.00%-800K | ---- | 95.31%-800K | ---- | -53.74%-17.05M | ---- | -10.88%-11.09M | 10.00%-9M | ---10M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---182.44M | ---182.44M | ---- |
| Net cash from financing operations | -56.84%-15.41M | 46.70%-30.33M | 59.37%-9.83M | 29.29%-56.9M | 56.38%-24.18M | 80.36%-80.47M | 74.04%-55.44M | -473.71%-409.68M | -70.28%-213.53M | 9.68%109.63M |
| Effect of rate | -3,466.67%-4.07M | 124.69%1.51M | 99.22%-114K | -169.49%-6.13M | -2,449.30%-14.58M | 41.26%-2.28M | -108.49%-572K | -115.64%-3.87M | -78.44%6.74M | 404.53%24.76M |
| Net Cash | 533.77%18.01M | -79.94%2.65M | -111.47%-4.15M | -4.91%13.22M | 410.37%36.18M | 59.67%13.9M | -107.05%-11.66M | 102.04%8.71M | 268.57%165.26M | -208.18%-427.16M |
| Begining period cash | 10.35%44.4M | 21.38%40.24M | 21.38%40.24M | 54.01%33.15M | 54.01%33.15M | 28.95%21.53M | 28.95%21.53M | -96.02%16.69M | -96.02%16.69M | 1,194.42%419.1M |
| Cash at the end | 62.18%58.34M | 10.35%44.4M | -34.29%35.97M | 21.38%40.24M | 488.80%54.75M | 54.01%33.15M | -95.07%9.3M | 28.95%21.53M | -46.44%188.69M | -96.02%16.69M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Tianjian International Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. | -- | Kaiyuan Xinde Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.